Compare Cassava Sciences Inc (FLNA) vs Marex Group Limited Ordinary Shares (MRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Marex Group Limited Ordinary Shares — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while Marex Group Limited Ordinary Shares trades at $71.17 (market cap $5.12B). The key difference: Marex Group Limited Ordinary Shares is far larger — about 129.9× Cassava Sciences Inc's market cap, and Marex Group Limited Ordinary Shares pays a 0.9% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Marex Group Limited Ordinary Shares for 0 Days on average.
| FLNA | MRX | |
|---|---|---|
Market Cap | $39.40M | $5.12B |
Volume | 759,018 | 647,370 |
Sector | Health | Financials |
52-Week High | $4.64 | $78.27 |
52-Week Low | $0.68 | $29.92 |
Typical Hold Time | 37 Days | 0 Days |
Enterprise Value | -$43.28M | $8.20B |
Dividend Yield | — | 0.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.8157, down 6.77% today, with a bearish technical signal from moving averages. The company shows improving quarterly EPS trends, beating expectations in recent quarters, though it remains unprofitable with negative ROE and ROA. Recent FDA clearance for its epilepsy drug trial provides a positive catalyst. Analyst sentiment is bullish with 67% buy ratings.
The outlook hinges on clinical progress; upside exists if Phase 2a trials succeed, but high cash burn and lack of revenue pose significant risks. Investors should weigh the strong analyst support against the company's financial challenges and binary clinical outcomes.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Marex Group Limited Ordinary Shares
Marex Group provides financial services across commodities, financial markets, and corporate clients. Its services include clearing, agency and execution, market making, hedging, and securities services.
Read more on MRX →
